Fund Holdings — Logos Global Management LP

Total Portfolio Value:
$562.54M
Total Bought:
$287.82M
Total Sold:
$408.01M
Net Transaction:
-$120.18M
Notable People:
Logos Global Management Gp Llc, Arsani Hany William, Graham Gordon Walmsley
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
IDEAYA Biosciences, Inc.(IDYA)3,000,0003,500,000+500,000$77.10M$57.33M10.19%-$19.77M
Revolution Medicines, Inc.(RVMD)1,450,0001,600,000+150,000$63.42M$56.58M10.06%-$6.85M
Akero Therapeutics Inc800,0001,200,000+400,000$22.26M$48.58M8.64%+$26.32M
Janux Therapeutics, Inc.(JANX)1,250,0001,650,000+400,000$66.92M$44.55M7.92%-$22.38M
Nuvalent Inc0500,000+500,000$0$35.46M6.30%+$35.46M
Teva Pharmaceutical Industries LimitedADS(TEVA)01,700,000+1,700,000$0$26.13M4.64%+$26.13M
Xenon Pharmaceuticals Inc.(XENE)0650,000+650,000$0$21.81M3.88%+$21.81M
Keros Therapeutics, Inc.(KROS)02,000,000+2,000,000$0$20.38M3.62%+$20.38M
Disc Medicine, Inc.(IRON)200,000394,342+194,342$12.68M$19.58M3.48%+$6.90M
BioNTech SEADS(BNTX)300,000200,000-100,000$34.19M$18.21M3.24%-$15.97M
89bio Inc02,500,000+2,500,000$0$18.18M3.23%+$18.18M
Soleno Therapeutics Inc350,000250,000-100,000$15.73M$17.86M3.18%+$2.13M
Erasca, Inc.(ERAS)12,500,00013,000,000+500,000$31.38M$17.81M3.17%-$13.56M
Ocular Therapeutix, Inc.(OCUL)3,500,0002,300,000-1,200,000$29.89M$16.86M3.00%-$13.03M
Design Therapeutics, Inc.(DSGN)4,217,6274,217,6270$26.02M$16.28M2.89%-$9.74M
MoonLake ImmunotherapeuticsCL A(MLTX)0350,000+350,000$0$13.67M2.43%+$13.67M
Geron Corporation(GERN)2,000,0008,000,000+6,000,000$7.08M$12.72M2.26%+$5.64M
Olema Oncology, Inc.(OLMA)3,208,8753,208,8750$18.71M$12.07M2.14%-$6.64M
Crinetics Pharmaceuticals In0350,000+350,000$0$11.74M2.09%+$11.74M
Avidity Biosciences Inc0350,000+350,000$0$10.33M1.84%+$10.33M
Maze Therapeutics, Inc.(MAZE)0936,914+936,914$0$10.32M1.83%+$10.32M
Annexon, Inc.(ANNX)2,550,0004,000,000+1,450,000$13.08M$7.72M1.37%-$5.36M
Structure Therapeutics IncADS700,000425,000-275,000$18.98M$7.36M1.31%-$11.63M
COMPASS Pathways plcADS(CMPS)02,000,000+2,000,000$0$5.72M1.02%+$5.72M
Dyne Therapeutics, Inc.(DYN)450,000500,000+50,000$10.60M$5.23M0.93%-$5.37M
Enliven Therapeutics Inc140,000240,000+100,000$3.15M$4.72M0.84%+$1.57M
Immunovant, Inc.(IMVT)300,000275,000-25,000$7.43M$4.70M0.84%-$2.73M
Aerovate Therapeutics Inc1,400,0001,400,0000$3.71M$3.51M0.62%-$196.0K
Aclaris Therapeutics, Inc.(ACRS)2,222,2222,222,2220$5.51M$3.40M0.60%-$2.11M
Unicycive Therapeutics Inc5,078,9275,078,9270$4.03M$2.92M0.52%-$1.11M
Trevi Therapeutics, Inc.(TRVI)1,250,000424,715-825,285$5.15M$2.67M0.47%-$2.48M
Astria Therapeutics Inc500,000500,0000$4.47M$2.67M0.47%-$1.80M
Rapport Therapeutics, Inc.(RAPP)208,910208,9100$3.71M$2.10M0.37%-$1.61M
Glycomimetics Inc5,400,0005,400,0000$1.34M$1.13M0.20%-$210.6K
Septerna, Inc.(SEPN)134,202134,2020$3.07M$777.0K0.14%-$2.30M
Allakos Inc2,900,0002,900,0000$3.51M$660.0K0.12%-$2.85M
Artiva Biotherapeutics, Inc.(ARTV)145,089145,0890$1.46M$435.3K0.08%-$1.03M
Solid Biosciences Inc0100,000+100,000$0$370.0K0.07%+$370.0K
Nuvation Bio Inc.W EXP 02 10 202(NUVB)66,66666,6660$15.3K$15.9K0.00%+$587
Alkermes plcSHS(ALKS)500,0000-500,000$14.38M$0—-$14.38M
Apellis Pharmaceuticals Inc
COM
500,0000-500,000$15.96M$0—-$15.96M
Apogee Therapeutics Inc300,0000-300,000$13.59M$0—-$13.59M
Arvinas, Inc.(ARVN)700,0000-700,000$13.42M$0—-$13.42M
Atyr Pharma Inc1,000,0000-1,000,000$3.62M$0—-$3.62M
Blueprint Medicines Corp200,0000-200,000$17.44M$0—-$17.44M
Bright Minds Biosciences Inc.(DRUG)245,0000-245,000$8.82M$0—-$8.82M
Cytokinetics, Incorporated(CYTK)900,0000-900,000$42.34M$0—-$42.34M
Edgewise Therapeutics, Inc.(EWTX)400,0000-400,000$10.68M$0—-$10.68M
Insmed Incorporated(INSM)450,0000-450,000$31.07M$0—-$31.07M
Jazz Pharmaceuticals plcSHS USD(JAZZ)175,0000-175,000$21.55M$0—-$21.55M
Merus N V750,0000-750,000$31.54M$0—-$31.54M
Neurocrine Biosciences, Inc.(NBIX)200,0000-200,000$27.30M$0—-$27.30M
Pliant Therapeutics, Inc.(PLRX)750,0000-750,000$9.88M$0—-$9.88M
Spyre Therapeutics, Inc.(SYRE)500,0000-500,000$11.64M$0—-$11.64M
Travere Therapeutics, Inc.(TVTX)1,000,0000-1,000,000$17.42M$0—-$17.42M
Vaxcyte, Inc.(PCVX)300,0000-300,000$24.56M$0—-$24.56M
Vera Therapeutics, Inc.CL A(VERA)875,0000-875,000$37.00M$0—-$37.00M
Y-Mabs Therapeutics Inc1,000,0000-1,000,000$7.83M$0—-$7.83M
Page 1 of 1
Logos Global Management LP — 13F Holdings — Q1 2025 | TickerTrail